FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Marrone Pamela G   2. Issuer Name and Ticker or Trading Symbol MARRONE BIO INNOVATIONS INC [MBII] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) CEO and President (Last) (First) (Middle) C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, SUITE A-107 3. Date of Earliest Transaction (Month/Day/Year) 08/07/2013 (Street) DAVIS, CA 95618 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 08/07/2013   C   3,416 A (1) 51,314 I Jointly with Spouse Common Stock 08/07/2013   C   1,820 A (2) 53,134 I Jointly with Spouse Common Stock 08/07/2013   C   689 A (3) 6,442 I By Trust 42) Common Stock               712,375 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Convertible Promissory Note

$ 8.4

08/07/2013

C

$ 28,695 (1)

(1)

(1)

Common Stock

3,416

$ 25,000 (5)

0

I

Jointly with Spouse

Convertible Promissory Note

$ 8.4

08/07/2013

C

$ 15,292 (2)

(2)

(2)

Common Stock

1,820

$ 15,000 (6)

0

I

Jointly with Spouse

Convertible Promissory Note

$ 8.4

08/07/2013

C

$ 5,795 (3)

(3)

(3)

Common Stock

689

$ 5,049 (5)

0

I

By Trust (4)

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Marrone Pamela G C/O MARRONE BIO INNOVATIONS, INC. 2121 SECOND STREET, SUITE A-107 DAVIS, CA 95618	X		CEO and President

Signatures

/s/ Donald J. Glidewell, Donald J. Glidewell, Attorney-in-Fact		08/09/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Principal and accrued interest of $28,695 under a convertible promissory note automatically converted into common stock upon the completion of the Issuer's initial public offering at a rate of $8.40 per share.
(2)	Principal and accrued interest of $15,292 under a convertible promissory note automatically converted into common stock upon the completion of the Issuer's initial public offering at a rate of $8.40 per share.
(3)	Principal and accrued interest of $5,795 under a convertible promissory note automatically converted into common stock upon the completion of the Issuer's initial public offering at a rate of $8.40 per share.
(4)	Ownership is held by Florence H. Marrone TOD Pamela G. Marrone.
(5)	Lists original principal under the convertible promissory note as of March 16, 2012, the date of purchase.
(6)	Lists original principal under the convertible promissory note as of May 28, 2013, the date of purchase.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.